209 related articles for article (PubMed ID: 28538494)
41. Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.
Oltean HN; Lofy KH; Goldoft MJ; DeBolt CA
Public Health Rep; 2016; 131(3):474-82. PubMed ID: 27252567
[TBL] [Abstract][Full Text] [Related]
42. Rationale for reducing the spread of human papillomavirus in adolescents: strategies to improve outcomes (CME multimedia activity).
Alexander K; Daley AM; Dempsey AF
J Adolesc Health; 2012 May; 50(5):IBC. PubMed ID: 22525122
[TBL] [Abstract][Full Text] [Related]
43. A model of health care provider decision making about HPV vaccination in adolescent males.
Alexander AB; Best C; Stupiansky N; Zimet GD
Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
[TBL] [Abstract][Full Text] [Related]
44. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions?
Elst L; Albersen M
Semin Oncol Nurs; 2022 Jun; 38(3):151284. PubMed ID: 35577640
[TBL] [Abstract][Full Text] [Related]
45. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
Mahoney MC
J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
[TBL] [Abstract][Full Text] [Related]
47. Mandatory HPV Vaccination; Opportunity to Save Lives, Improve Readiness and Cut Costs.
Sitler CA; Weir LF; Keyser EA; Casablanca Y; Hope E
Mil Med; 2021 Nov; 186(11-12):305-308. PubMed ID: 34117500
[TBL] [Abstract][Full Text] [Related]
48. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
49. Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
Gordon J; Bail J
NASN Sch Nurse; 2023 May; 38(3):114-120. PubMed ID: 36691362
[TBL] [Abstract][Full Text] [Related]
50. Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK.
Datta S; Pink J; Medley GF; Petrou S; Staniszewska S; Underwood M; Sonnenberg P; Keeling MJ
BMC Infect Dis; 2019 Jun; 19(1):552. PubMed ID: 31234784
[TBL] [Abstract][Full Text] [Related]
51. The human papillomavirus vaccines.
Ljubojević S
Acta Dermatovenerol Croat; 2006; 14(3):208. PubMed ID: 17010274
[TBL] [Abstract][Full Text] [Related]
52. The Expanded Impact of Human Papillomavirus Vaccine.
Pahud BA; Ault KA
Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
[TBL] [Abstract][Full Text] [Related]
53. Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.
Laprise JF; Drolet M; Boily MC; Jit M; Sauvageau C; Franco EL; Lemieux-Mellouki P; Malagón T; Brisson M
Vaccine; 2014 Oct; 32(44):5845-53. PubMed ID: 25131743
[TBL] [Abstract][Full Text] [Related]
54. Age considerations when vaccinating against HPV.
Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
[TBL] [Abstract][Full Text] [Related]
55. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus disease in adolescents: management and prevention.
Widdice LE
Adolesc Med State Art Rev; 2012 Apr; 23(1):192-206, xii-xiii. PubMed ID: 22764563
[TBL] [Abstract][Full Text] [Related]
57. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
[TBL] [Abstract][Full Text] [Related]
58. Acceptability of human papillomavirus vaccine for males: a review of the literature.
Liddon N; Hood J; Wynn BA; Markowitz LE
J Adolesc Health; 2010 Feb; 46(2):113-23. PubMed ID: 20113917
[TBL] [Abstract][Full Text] [Related]
59. Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.
Cullen KA; Stokley S; Markowitz LE
Acad Pediatr; 2014; 14(5):497-504. PubMed ID: 24954170
[TBL] [Abstract][Full Text] [Related]
60. Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
Bednarczyk RA; Ellingson MK; Omer SB
J Infect Dis; 2019 Jul; 220(5):730-734. PubMed ID: 30657920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
